Climb Bio (CLYM) Stock Chart & Stock Price History $2.25 -0.15 (-6.25%) As of 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Climb Bio Stock Price Performance The Climb Bio (CLYM) stock chart highlights key performance trends across multiple timeframes. Since the beginning of the year, the stock increased 25.00%. In the past month, the stock has increased 39.75%, reflecting recent market activity. As of the latest close, Climb Bio traded at $2.40 with a market cap of $162.62 million and volume of 224,101 shares. Receive CLYM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Climb Bio and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-5.86%1 Month Performance+39.75%3 Month Performance+75.78%Year-To-Date Performance+25.00% CLYM Stock Chart for Friday, September, 12, 2025 CLYM Chart by TradingView Climb Bio Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization09/11/2025$2.38$2.40+0.84%$2.42$2.37224,101 shs$162.62 million09/10/2025$2.38$2.38$2.48$2.33258,557 shs$161.28 million09/09/2025$2.47$2.38-3.64%$2.55$2.36253,931 shs$161.27 million09/08/2025$2.39$2.47+3.35%$2.53$2.43676,836 shs$167.37 million09/05/2025$2.33$2.39+2.58%$2.43$2.35646,277 shs$161.95 million09/04/2025$2.44$2.33-4.51%$2.45$2.26395,099 shs$157.89 million09/03/2025$2.23$2.44+9.42%$2.49$2.20638,812 shs$165.33 million09/02/2025$2.23$2.23$2.26$2.12323,222 shs$151.11 million09/01/2025$2.23$2.23$2.38$2.22288,883 shs$151.11 million08/29/2025$2.30$2.23-3.04%$2.38$2.22288,883 shs$151.11 million Get the Latest News and Ratings for CLYM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Climb Bio and its competitors with MarketBeat's FREE daily newsletter. 08/28/2025$2.29$2.30+0.44%$2.38$2.28241,295 shs$155.85 million08/27/2025$2.33$2.29-1.72%$2.41$2.20618,774 shs$155.17 million08/26/2025$2.48$2.33-6.05%$2.50$2.27702,064 shs$157.89 million08/25/2025$2.38$2.48+4.20%$2.52$2.351.05 million shs$168.05 million08/22/2025$2.19$2.38+8.68%$2.42$2.17799,762 shs$161.27 million08/21/2025$2.25$2.19-2.67%$2.28$2.14640,116 shs$148.39 million08/20/2025$2.02$2.25+11.39%$2.29$1.98872,186 shs$152.47 million08/19/2025$2.11$2.02-4.27%$2.26$2.01837,361 shs$136.88 million08/18/2025$1.90$2.11+11.05%$2.15$1.931.65 million shs$142.97 million08/15/2025$1.72$1.90+10.47%$1.93$1.731.15 million shs$128.74 million08/14/2025$1.63$1.72+5.52%$1.72$1.61396,253 shs$116.24 million08/13/2025$1.61$1.63+1.24%$1.69$1.60383,270 shs$110.15 million08/12/2025$1.65$1.61-2.42%$1.68$1.55482,528 shs$108.80 million08/11/2025$1.70$1.65-2.94%$1.72$1.64370,153 shs$111.51 million Related Companies Tyra Biosciences Stock Chart Bicara Therapeutics Stock Chart Terns Pharmaceuticals Stock Chart Tourmaline Bio Stock Chart Keros Therapeutics Stock Chart AnaptysBio Stock Chart Rezolute Stock Chart Organogenesis Stock Chart Septerna Stock Chart Siga Technologies Stock Chart Receive CLYM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Climb Bio and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CLYM) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | Sponsored6-Figure Target for BTC by 2025Trump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredDo NOT Day Trade (Do THIS instead)Forget day trading (especially in markets like these). Trade OVERNIGHT instead! I've uncovered a shockin...Monument Traders Alliance | SponsoredWall Street laughed at Trump’s “Smart Dollar.” Now they’re all in."THIS is the Biggest Economic Story of 2025" While most Americans are focused on tariffs and inflation, the...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Climb Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Climb Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
